Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Blood cells from 80-year-old donor become stem cells with molecular age under 20 (opens in a new tab)

medicalxpress.com · 2026-10-09

Short answerEvidenceSource

Short answer

Not supported

Not supported.

One claim goes further than the study. 3 other points were not covered by the paper.

  • 1 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Not supported

One claim overstates the study. Three claims the study doesn't address.

  • 1 overstated
  • 3 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4OverstatedResearchers from the University Hospital of Bonn and the University of Bonn succeeded in dramatically rejuvenating human cells in a test tube by directly reprogramming red blood cell precursors into stem cells from which neurons can be derived.View evidenceHide evidence

Why this verdict

The abstract supports direct conversion of human erythroid progenitors into induced neural stem cells and pronounced epigenetic de-aging measured by a DNA-methylation clock. However, the headline-style claim that researchers 'dramatically rejuvenated human cells' is broader than the abstract evidence, which is specifically molecular/epigenetic and does not establish broad functional rejuvenation. The headline wording outruns the more careful body framing about epigenetic or molecular age.

1

Study evidence

Direct conversion of human erythroid progenitors to iNSCs is achieved by overexpressing SOX2 and cMYC across donors from neonatal to 101 years of age.

“we used overexpression of the two reprogramming factors SOX2 and cMYC to generate iNSCs from erythroid progenitors of donors ranging from neonatal to 101 years of age.”
2

Study evidence

Established iNSC lines lack age-associated cellular hallmarks, described as similar to iPSCs and their derivatives.

“Concordant with this observation, established iNSC lines lack age‐associated cellular hallmarks, similar to induced pluripotent stem cells and their derivatives.”
Claim 2 of 4Not coveredDuring the reprogramming process, the cells' molecular clocks were reset, and blood cells from an 80-year-old donor were transformed into stem cells with a molecular age of less than 20 years.View evidenceHide evidence

As statedfrom 80 years old to less than 20 years old

Why this verdict

The abstract supports substantial epigenetic clock de-aging in aged-donor iNSCs, with about 13% and 5% of original donor epigenetic age retained at low and high passage. But the specific story example of an 80-year-old donor becoming molecularly younger than 20 is not directly verifiable from the abstract-level profile, which does not list individual donor ages/results or exact passage context for that example.

1

Study evidence

Direct conversion of human erythroid progenitors to iNSCs is achieved by overexpressing SOX2 and cMYC across donors from neonatal to 101 years of age.

“we used overexpression of the two reprogramming factors SOX2 and cMYC to generate iNSCs from erythroid progenitors of donors ranging from neonatal to 101 years of age.”
Claim 3 of 4Not coveredThe article says the rejuvenation occurred very slowly and over more than 100 days, making it suitable for detailed study of the underlying mechanisms.View evidenceHide evidence

As statedover 100 days

Why this verdict

The abstract supports that epigenetic de-aging is protracted over several weeks and that the slow dynamics make the system useful for studying mechanisms of transdifferentiation and epigenetic rejuvenation. The specific duration 'over more than 100 days' is not available in the abstract-level profile, so that magnitude cannot be verified at this depth.

1

Study evidence

Epigenetic de‑aging during iNSC conversion is protracted over several weeks and continues even when proliferation is experimentally inhibited.

“Studying the dynamics of epigenetic de‐aging during iNSC conversion across time, we found that this process is largely protracted, continuing for several weeks and even under proliferation‐inhibiting conditions.”
2

Study evidence

Integrated time-course DNA methylation and RNA-seq analyses indicate that acquisition of a bona fide NSC molecular signature extends substantially beyond the time point when proliferative PAX6-positive iNSCs first emerge.

“time course analysis of DNA methylation and RNA sequencing data revealed that acquisition of a bona fide NSC signature extends greatly beyond the time point when proliferative PAX6‐positive iNSCs emerge.”
Claim 4 of 4Not coveredThe publication is said to be in Aging Cell and is titled Protracted Fate Acquisition and Epigenetic De‐Aging During Induced Neural Stem Cell Conversion of Human Blood Cells.View evidenceHide evidence

Why this verdict

The supplied paper profile does not provide bibliographic metadata sufficient to verify the journal name or exact title. This claim may be true, but it is not verifiable from the abstract-level scientific profile provided here.

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Transcriptomic differences between young- and old-donor iNSCs dissipate with extended time in conversion, and established lines lack age-associated cellular hallmarks.

    The story focuses on epigenetic clock rejuvenation and slow conversion, but does not report the transcriptomic convergence or the cellular-hallmark findings described in the abstract.

    From ex vivo human; ex vivo human

  • Acquisition of a bona fide neural stem cell molecular signature extends well beyond the initial emergence of proliferative PAX6-positive iNSCs.

    This time-course multi-omics/state-acquisition result is a material secondary finding in the paper profile, but it is not covered in the story presentation.

    From time-course multi-omics integration

3 things the story did carry across
  • Human erythroid progenitors from donors across a wide age range were directly converted to induced neural stem cells without passing through a pluripotent stage.
  • The main rejuvenation evidence is methylation-clock epigenetic de-aging, with aged-donor iNSCs retaining about 13% of donor epigenetic age at low passage and about 5% at high passage.
  • Epigenetic de-aging during conversion is protracted over weeks and can continue even under proliferation-inhibiting conditions.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

5

Evidence read

study summary

Lead result

ex vivo human

1Lead resultex vivo humanInduced neural stem cells (iNSCs) can be generated from human erythroid progenitors across a wide donor age range using SOX2 and cMYC, and iNSCs from aged donors show pronounced epigenetic de-aging that increases with passage.direct conversion (SOX2 + cMYC)Expand

In plain English

Using overexpression of SOX2 and cMYC, human erythroid progenitors from donors spanning neonatal to 101 years were directly converted to induced neural stem cells (iNSCs). Epigenetic age estimated by a DNA methylation clock was markedly reduced in iNSCs derived from aged donors, with iNSCs preserving around 13% and 5% of the original donor epigenetic age at low and high passage, respectively. Epigenetic de-aging progressed over an extended time course (weeks), occurred even under proliferation-inhibiting conditions, and transcriptomic differences between young- and old-donor iNSCs diminished with extended time in conversion.

Key findings

  • Direct conversion of human erythroid progenitors to iNSCs is achieved by overexpressing SOX2 and cMYC across donors from neonatal to 101 years of age.
  • iNSCs derived from aged donors show pronounced epigenetic de-aging as measured by a DNA methylation aging clock, preserving around 13% and 5% of the original donor epigenetic age at low and high passages, respectively.preserving ~13% (low passage) and ~5% (high passage) of original donor epigenetic age
“we used overexpression of the two reprogramming factors SOX2 and cMYC to generate iNSCs from erythroid progenitors of donors ranging from neonatal to 101 years of age.”
What this piece can’t prove

4 further details could not be confirmed from the summary.

2ex vivo humanEpigenetic de-aging during iNSC conversion is protracted over weeks, continues during the conversion time course, and can proceed even under proliferation-inhibiting conditions.Longitudinal direct conversion with proliferation‑inhibition perturbationExpand

In plain English

Using SOX2 and cMYC-driven direct conversion of human erythroid progenitors to induced neural stem cells (iNSCs), the study reports that epigenetic de‑aging measured by a DNA methylation aging clock is a protracted process that continues for several weeks during the conversion time course and persists even under experimentally imposed proliferation‑inhibiting conditions. Transcriptomic differences between iNSCs derived from young versus old donors diminish with extended time in conversion, and acquisition of a canonical NSC transcriptional signature occurs substantially later than the initial appearance of proliferative PAX6+ iNSCs. Details on inhibitor identity, timepoints, and sample sizes are not provided in the abstract.

Key findings

  • Epigenetic de‑aging during iNSC conversion is protracted over several weeks and continues even when proliferation is experimentally inhibited.
  • Transcriptomic differences between young and old donor‑derived iNSCs dissipate with extended time in conversion.
“Studying the dynamics of epigenetic de‐aging during iNSC conversion across time, we found that this process is largely protracted, continuing for several weeks and even under proliferation‐inhibiting conditions.”
What this piece can’t prove
  • Summary and findings are based on abstract information only; the abstract omits key experimental details necessary to fully appraise the time‑course and perturbation (e.g., inhibitor identity/dose, validation of proliferation arrest).
  • Abstract does not report sample sizes, donor distribution per timepoint, exact timepoints sampled, or statistical effect sizes and p‑values for the reported temporal trends.

2 further details could not be confirmed from the summary.

3ex vivo humanTranscriptomic differences between young- and old-donor derived iNSCs dissipate with extended time in conversion, and established iNSC lines lack age-associated cellular hallmarks similar to iPSCs and derivatives.Expand

In plain English

Time-course RNA sequencing of iNSCs derived from donors spanning neonatal to 101 years shows that age-associated transcriptomic differences between young- and old-donor derived iNSCs dissipate with extended time in conversion. Established iNSC lines lack age-associated cellular hallmarks, resembling induced pluripotent stem cells and their derivatives. DNA methylation and RNA-seq time-course data are reported as concordant with prolonged transcriptional and epigenetic remodeling, but the abstract does not provide details on sample sizes, specific analysis methods, or timepoint resolution.

Key findings

  • Transcriptomic differences between young- and old-donor derived iNSCs dissipate with extended time in conversion; established iNSC lines lack age-associated cellular hallmarks, similar to iPSCs and their derivatives.
“Transcriptomic differences between young and old donor‐derived iNSCs dissipate with extended time in conversion, too.”
What this piece can’t prove
  • The abstract lacks details on RNA-seq modality (bulk vs single-cell), library prep, sequencing depth, normalization, batch correction, and specific differential-expression or time-course modeling approaches.

3 further details could not be confirmed from the summary.

4ex vivo humanTranscriptomic differences between young- and old-donor derived iNSCs dissipate with extended time in conversion, and established iNSC lines lack age-associated cellular hallmarks similar to iPSCs and derivatives.Expand

In plain English

In this study, established induced neural stem cell (iNSC) lines derived from human erythroid progenitors (donors ranged neonatal to 101 years) were reported to lack age-associated cellular hallmarks, a phenotype described as similar to induced pluripotent stem cells (iPSCs) and their derivatives. The authors also report that transcriptomic differences between young- and old-donor iNSCs dissipate with extended time in conversion.

Key findings

  • Established iNSC lines lack age-associated cellular hallmarks, described as similar to iPSCs and their derivatives.
  • Transcriptomic differences between young- and old-donor derived iNSCs dissipate with extended time in conversion.
“Concordant with this observation, established iNSC lines lack age‐associated cellular hallmarks, similar to induced pluripotent stem cells and their derivatives.”
What this piece can’t prove
  • Abstract lacks specification of which cellular aging hallmarks were assayed and which methods/assays were used to assess them.
  • Unclear whether cellular hallmark data derive from independent phenotypic assays versus inference from omics data; abstract wording suggests separate phenotyping but does not confirm.

2 further details could not be confirmed from the summary.

5ex vivo humanTime-course multi-omics indicates that acquisition of a bona fide NSC molecular signature extends well beyond the point when proliferative PAX6-positive iNSCs first emerge.time-course multi-omics integrationExpand

In plain English

Time-course integration of DNA methylation and RNA sequencing shows that acquisition of a bona fide neural stem cell (NSC) molecular signature occurs substantially later than the initial appearance of proliferative PAX6-positive induced NSCs (iNSCs).

Key findings

  • Integrated time-course DNA methylation and RNA-seq analyses indicate that acquisition of a bona fide NSC molecular signature extends substantially beyond the time point when proliferative PAX6-positive iNSCs first emerge.
“time course analysis of DNA methylation and RNA sequencing data revealed that acquisition of a bona fide NSC signature extends greatly beyond the time point when proliferative PAX6‐positive iNSCs emerge.”
What this piece can’t prove

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed · 17 candidate papers

Candidate

Programmed Clonal Expansion Associated with V(D)J Recombination Drives an ATM-Dependent Vulnerability Underlying Preferential Lymphocyte Depletion and Myeloid Bias Following DNA Damage.

bioRxiv : the Preprint Server for Biology · 2026 · PubMed

Tessa (opens in a new tab)Source (opens in a new tab)

And 11 more candidates considered.